Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 14.39
(-0.41%)
CNY 14.39
(-0.41%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 727.9 Million CNY | 107.12% |
| 2022 | 351.44 Million CNY | -50.12% |
| 2021 | 704.57 Million CNY | -24.9% |
| 2020 | 938.22 Million CNY | 7.61% |
| 2019 | 871.84 Million CNY | 2624.51% |
| 2018 | 32 Million CNY | 7.67% |
| 2017 | 29.72 Million CNY | 130.32% |
| 2016 | 12.9 Million CNY | -95.13% |
| 2015 | 265 Million CNY | 119.74% |
| 2014 | 120.59 Million CNY | -71.81% |
| 2013 | 427.86 Million CNY | 5.24% |
| 2012 | 406.57 Million CNY | 10.88% |
| 2011 | 366.68 Million CNY | 39.66% |
| 2010 | 262.55 Million CNY | 31.41% |
| 2009 | 199.79 Million CNY | -18.95% |
| 2008 | 246.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.93 Billion CNY | 166.34% |
| 2024 Q2 | 731.79 Million CNY | -62.25% |
| 2024 Q3 | 375.95 Million CNY | -47.43% |
| 2023 Q2 | 1.02 Billion CNY | 32.12% |
| 2023 FY | 727.9 Million CNY | 107.12% |
| 2023 Q1 | 775.31 Million CNY | 120.61% |
| 2023 Q3 | 1 Billion CNY | -1.92% |
| 2023 Q4 | 727.9 Million CNY | -27.55% |
| 2022 FY | 351.44 Million CNY | -50.12% |
| 2022 Q4 | 351.44 Million CNY | -24.35% |
| 2022 Q3 | 464.55 Million CNY | -35.24% |
| 2022 Q2 | 717.34 Million CNY | -18.28% |
| 2022 Q1 | 877.83 Million CNY | 24.59% |
| 2021 Q1 | 501.8 Million CNY | -46.52% |
| 2021 Q4 | 704.57 Million CNY | 0.72% |
| 2021 Q2 | 558.14 Million CNY | 11.23% |
| 2021 Q3 | 699.55 Million CNY | 25.34% |
| 2021 FY | 704.57 Million CNY | -24.9% |
| 2020 Q2 | 1.13 Billion CNY | 9.74% |
| 2020 FY | 938.22 Million CNY | 7.61% |
| 2020 Q3 | 1.03 Billion CNY | -8.59% |
| 2020 Q4 | 938.22 Million CNY | -9.73% |
| 2020 Q1 | 1.03 Billion CNY | 18.84% |
| 2019 FY | 871.84 Million CNY | 2624.51% |
| 2019 Q2 | 80 Million CNY | 3.71% |
| 2019 Q3 | 353.17 Million CNY | 341.47% |
| 2019 Q1 | 77.13 Million CNY | 141.05% |
| 2019 Q4 | 871.84 Million CNY | 146.86% |
| 2018 Q1 | 223.32 Million CNY | 651.41% |
| 2018 FY | 32 Million CNY | 7.67% |
| 2018 Q4 | 32 Million CNY | -44.36% |
| 2018 Q3 | 57.51 Million CNY | -47.71% |
| 2018 Q2 | 110 Million CNY | -50.74% |
| 2017 Q3 | 36.88 Million CNY | -50.7% |
| 2017 Q4 | 29.72 Million CNY | -19.42% |
| 2017 FY | 29.72 Million CNY | 130.32% |
| 2017 Q1 | 96.87 Million CNY | 650.73% |
| 2017 Q2 | 74.8 Million CNY | -22.78% |
| 2016 Q1 | 305.86 Million CNY | 15.42% |
| 2016 Q4 | 12.9 Million CNY | -63.24% |
| 2016 Q3 | 35.1 Million CNY | -29.65% |
| 2016 Q2 | 49.89 Million CNY | -83.69% |
| 2016 FY | 12.9 Million CNY | -95.13% |
| 2015 Q4 | 265 Million CNY | -36.11% |
| 2015 Q3 | 414.75 Million CNY | -8.79% |
| 2015 Q2 | 454.71 Million CNY | 375.09% |
| 2015 Q1 | 95.71 Million CNY | -20.63% |
| 2015 FY | 265 Million CNY | 119.74% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q4 | 120.59 Million CNY | -80.22% |
| 2014 Q2 | 574.78 Million CNY | 0.0% |
| 2014 Q3 | 609.76 Million CNY | 6.08% |
| 2014 FY | 120.59 Million CNY | -71.81% |
| 2013 Q4 | 427.86 Million CNY | 0.0% |
| 2013 FY | 427.86 Million CNY | 5.24% |
| 2012 FY | 406.57 Million CNY | 10.88% |
| 2011 FY | 366.68 Million CNY | 39.66% |
| 2010 FY | 262.55 Million CNY | 31.41% |
| 2009 FY | 199.79 Million CNY | -18.95% |
| 2008 FY | 246.5 Million CNY | 0.0% |